ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,957Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 3734

$1.4M Total Retail Price of All Prescriptions

Rank: 26 out of 3734

592 Patients Receiving at Least One Drug in Part D
36%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 592 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 592 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

4% of this provider’s 10,616 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 1,045 572 1 3
BENZTROPINE MESYLATE 669 249 R 2 173
METFORMIN HCL 649 256 3 8
AMLODIPINE BESYLATE 627 395 4 5
OMEPRAZOLE 598 288 5 4
SIMVASTATIN 500 308 6 1
TRAMADOL HCL 409 165 7 20
ZOLPIDEM TARTRATE 396 133 8 24
METOPROLOL TARTRATE 379 186 9 6
VENTOLIN HFA 377 156 10 70
FUROSEMIDE 360 179 11 7
HALOPERIDOL 357 152 12 212
MELOXICAM 352 209 13 52
RANITIDINE HCL 342 165 14 32
HYDROCHLOROTHIAZIDE 334 97 15 9
RISPERIDONE 323 141 16 62
IBUPROFEN 277 85 17 75
PRAVASTATIN SODIUM 265 168 18 15
GABAPENTIN 265 105 18 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 264 115 20 27
OLANZAPINE 251 112 21 106
DIVALPROEX SODIUM 246 82 22 99
SERTRALINE HCL 241 117 23 18
NAPROXEN 214 49 24 101
LEVOTHYROXINE SODIUM 213 65 25 2
TAMSULOSIN HCL 206 165 26 29
TRAZODONE HCL 201 107 27 49
ADVAIR DISKUS 199 76 28 35
CARVEDILOL 196 105 29 30
QUETIAPINE FUMARATE 195 71 30 82
TRICOR 194 45 31 93
SINGULAIR 190 87 32 95
CYCLOBENZAPRINE HCL 189 43 R 33 87
ABILIFY 186 28 34 159
BUSPIRONE HCL 185 72 35 129
FLUOXETINE HCL 176 69 36 61
DONEPEZIL HCL 174 127 37 25
CITALOPRAM HBR 170 44 38 16
ENDOCET 156 67 S2 39 89
CLOPIDOGREL 155 102 40 23
VESICARE 151 77 41 157
FLUTICASONE PROPIONATE 147 54 42 46
FAMOTIDINE 143 83 43 60
JANUVIA 142 60 44 50
AZITHROMYCIN 140 42 45 38
ACTOS 140 73 45 110
ATORVASTATIN CALCIUM 139 80 47 11
INSULIN SYRINGE 138 62 48 109
NIFEDIPINE ER 132 87 49 113
HYDROCORTISONE 129 57 50 217
POTASSIUM CHLORIDE 123 98 51 19
GLIPIZIDE 123 34 51 57
PHENYTOIN SODIUM EXTENDED 122 52 53 149
GLIMEPIRIDE 122 72 53 37
LYRICA 121 37 55 124
DICLOFENAC SODIUM 117 53 56 127
MIRTAZAPINE 116 65 57 45
LOSARTAN POTASSIUM 116 75 57 21
CYMBALTA 114 30 59 67
PROAIR HFA 110 32 60 83
LEVETIRACETAM 110 50 60 105
PANTOPRAZOLE SODIUM 107 60 62 22
PLAVIX 105 75 63 39
PROMETHAZINE HCL 104 20 R 64 185
MONTELUKAST SODIUM 100 43 65 175
LOSARTAN-HYDROCHLOROTHIAZIDE 96 43 66 71
SPIRIVA 94 30 67 40
KETOCONAZOLE 93 17 68 204
FLUPHENAZINE HCL 90 43 69 441
ISOSORBIDE MONONITRATE ER 90 63 69 34
MUPIROCIN 89 32 71 189
ATENOLOL 89 76 71 13
DIVALPROEX SODIUM ER 87 26 73 198
HYDROCODONE-ACETAMINOPHEN 87 21 S3 73 12
ALENDRONATE SODIUM 83 64 75 26
ROPINIROLE HCL 83 45 75 118
JANUMET 83 65 75 180
VENLAFAXINE HCL ER 82 29 78 84
DIOVAN HCT 82 45 78 72
ZIPRASIDONE HCL 80 26 80 488
DIOVAN 79 30 81 31
COREG CR 75 38 82 334
ESCITALOPRAM OXALATE 73 21 83 68
UNIFINE PENTIPS 70 26 84 384
LOVASTATIN 70 29 84 41
SINGLE USE SWAB 70 25 84 292
SUBOXONE 70 0 84 138
HYDRALAZINE HCL 70 58 84 111
SEROQUEL XR 69 45 89 287
HYDROXYZINE PAMOATE 69 0 R 89 255
ENALAPRIL MALEATE 69 52 89 63
DETROL LA 69 50 89 153
CEPHALEXIN 67 34 93 120
OXYBUTYNIN CHLORIDE 67 55 93 151
ALCOHOL SWABS 66 27 95 290
ZYPREXA 66 27 95 512
CRESTOR 64 19 97 28
GLYBURIDE 64 17 R 97 64
LAMOTRIGINE 64 0 97 169
GEMFIBROZIL 64 32 97 114
AMLODIPINE BESYLATE-BENAZEPRIL 63 16 101 56
MECLIZINE HCL 62 41 102 139
TERAZOSIN HCL 61 39 103 136
NIASPAN 61 38 103 125
DOXAZOSIN MESYLATE 60 39 105 100
NEXIUM 60 47 105 36
HUMALOG MIX 75-25 58 14 107 253
SEROQUEL 54 29 108 161
AMOX TR-POTASSIUM CLAVULANATE 53 21 109 164
PIOGLITAZONE HCL 53 25 R 109 282
LEVEMIR FLEXPEN 53 13 109 184
LANTUS 52 33 112 54
HYDROXYZINE HCL 51 33 R 113 208
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.